by admin | Dec 8, 2021 | Business, Funding, Healthcare, Research
Hemostatics is a spin-off company from Cima Universidad de Navarra. Hemostatics Pharmaceuticals is performing the preclinical and clinical development of the antifibrinolytic agent CM-352, a first-in-class drug that represents a pioneering therapeutic approach to...
by admin | Jun 30, 2020 | Funding
Novo Ventures, part of Novo Holdings, today announced that it has led the $55 million (£44 million) Series B financing in NodThera, a UK and US based clinical stage biotechnology company developing a new class of medicines to treat diseases driven by chronic...
by admin | Jun 30, 2020 | Funding
Solvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion Global Pharmaceutical Laboratory Services Company Appoints Two Seasoned Industry Executives to Board of Directors – Solvias Completes Agreement with Strategic Healthcare...
by admin | Nov 25, 2019 | Funding
Azeria Therapeutics, a newly formed pioneer factor drug discovery company, announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund. Azeria was originally founded in 2017 by Sixth Element...
by admin | Nov 18, 2019 | Funding
LUNAC Therapeutics has spun out of the University of Leeds with €3.09M of funding from the university and the VC firm Epidarex Capital for the development of anticoagulants with a lower risk for bleeding than those currently available. The new anticoagulants will...
by admin | Nov 18, 2019 | Funding, Partnerships
FUJIFILM Diosynth Biotechnologies will be expanding its gene therapy process and analytical development capabilities with the addition of new dedicated laboratorios. FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and...
